Personnel Moves Archives - Page 2 of 42

Roman to move out of CEO post at 3M, successor named

3M CEO Mike Roman [Photo courtesy of 3M]3M (NYSE: MMM) + announced today that it selected William M. Brown to succeed Mike Roman as CEO.

Brown’s appointment to the corner office goes into effect on May 1, 2024. Roman will shift to the role of executive chair of 3M’s board of directors with the same effective date.

“Bill’s strong track record as a CEO for a global technology company makes him the right leader for 3M,” Roman said in a news release. “He brings a wealth of experience in strategic leadership, innovation, and operational excellence to 3M. I look forward to working with him to build on our momentum in my new role as executive chairman.”

News of the shift at the top of 3M comes at an interesting time, as the manufacturing giant prepares to spin off its Solventum healthcare business.

Brown, 61, previously served as chair and CEO at L3Harris Technologies, an a…

Natus Neuro taps Philips, Medtronic veteran as CEO

[Chris Landon portrait photo courtesy of Natus]Natus Medical (Middleton, Wisconsin) recently announced that a well-known executive in the Minneapolis-St. Paul medical device hub is the new CEO of its Natus Neuro business.

Chris Landon joined Natus last month after serving for four years as the president and GM of Image Guided Therapy Devices at Philips. Before Philips, Landon worked at Medtronic for 16 years. At the world’s largest medtech company, he held VP and GM roles in charge of degenerative spine treatment tech, biologics and diagnostics.

Landon is also vice chair of the board for the Medical Alley Association trade group in Minnesota.

The company said in a LinkedIn post: “With a proven track record of driving innovation and fostering patient-focused organizational culture, Chris’s leadership and expertise will propel our mission of advancing neurodiagnostics and improving patient outcomes around the globe to new heights.”

…

Endologix picks former Medtronic leader as new chief commercial officer

Endologix announced today that it appointed Mike Mathias as its new chief commercial officer (CCO), effective immediately.

Mathias brings 30 years of experience leading commercial organizations within the cardiovascular area. He most recently served as VP of commercial operations at Limflow. He held that role from 2022 until Inari Medical acquired the chronic limb-threatening ischemia (CLTI) treatment maker last year.

At Endologix, his role includes overseeing commercial operations for the artery disease treatment developer.

“Joining Endologix at such a critical juncture is an honor,” Mathias said in a news release. “I am excited to apply my experience to innovate and join the leadership team of a company that stands at the forefront of interventional vascular therapies. Together, we will work to enhance our commercial strategy, ensuring success for our commercial teams and the organization as a whole.”

Before LimFlow, Math…

Orthofix announces new president of Bone Growth Therapies

Jason Shallenberger, Orthofix’s new president of Bone Growth Therapies [Image courtesy of Orthofix]Orthofix Medical (NASDAQ:OFIX) is promoting from within to fill a new business president position at the company.

The Lewisville, Texax–base spine and ortho tech company announced today that it moving its Bone Growth Therapies business out from under the leadership of its Spine business.

Jason Shallenberger, previously the VP of U.S. sales and marketing for the Bone Growth Therapies business, is now Orthofix’s president of Bone Growth Therapies.

“Jason has led sales and marketing for this successful franchise for a number of years,” Orthofix President and CEO Massimo Calafiore said in a news release. “Under his guidance, the sales team has produced quarter-after-quarter of double-digit growth in 2023. I am confident he will do an amazing job as President and continue to contribute greatly to the success of Orthofix.”

Shallenberger said he wa…

Endoscopic ultrasound company EndoSound has a new CEO

New EndoSound CEO Scott Aldrich Jr. [Image from Scott Aldrich Jr. on LinkedIn]EndoSound announced today that it appointed Scott Aldrich Jr. as its new CEO in a move that went into effect on Feb. 1.

Dr. Stephen Steinberg, who previously served as president and CEO, remains on the Portland, Oregon–based company’s leadership team as chief medical officer.

Aldrich most recently served as an independent consultant focusing on medical device strategy, commercialization and operations. According to LinkedIn, he also served as VP of commercial & strategy at Motus GI from January 2023 to July 2023, having been VP of global marketing & strategy from September 2019 until the start of 2023.

In a news release, EndoSound said Aldrich brings operational and commercial leadership abilities paired with experience in both interventional gastroenterology and medical device imaging. His experience also spans startups and small/mid-cap companies, both privately an…

AbbVie president and COO to move into corner office

Robert Michael is slated to become AbbVie’s CEO in July 2024. [Image courtesy of AbbVie]

AbbVie (NYSE: ABBV) recently announced that its board of directors has decided to promote the company’s president and COO Robert A. Michael into the corner office.

Michael will succeed Richard A. Gonzalez, who is retiring as CEO on July 1. Gonzalez will stay as executive chair of AbbVie’s board.

“On behalf of AbbVie’s board, I am extremely excited that Rob has agreed to serve as AbbVie’s next CEO,” Gonzalez said in a Feb. 20 news release.

“As a key member of the executive leadership team, he has had a tremendous impact on AbbVie. From establishing our financial planning organization, to the development of our diversified business strategy, to successfully navigating the end of exclusivity for Humira in the U.S., Rob has been integral to AbbVie’s impact since…

Philips tabs Stryker controller as next CFO

Philips proposed to appoint Charlotte Hanneman as its next CFO. [Image courtesy of Philips]Philips (NYSE: PHG) + announced today that it proposes to appoint Charlotte Hanneman as a member of its management board as chief financial officer (CFO).

The Dutch medtech giant proposed to make the appointment effective on Oct. 1, 2024. It must submit its proposal to the annual general meeting of shareholders scheduled for May 7, 2024.

Philips expects to have Hanneman join as a member of its executive committee on June 1, 2024. This begins her induction and transition into the role as she succeeds current CFO Abhijit Bhattacharya on Oct. 1, following his retirement.

Roy Jakobs, CEO of Royal Philips said: “I would like to thank Abhijit for his significant contribution to the transformation of Philips into a health technology company. His dedication and leadership have made a major impact throughout his long 37-year career in…

Integra LifeSciences CEO Jan De Witte to retire

Incoming Integra Lifesciences CEO Jan D. De Witte [Image courtesy of Integra]Integra LifeSciences (Nasdaq: IART) + announced today that President and CEO Jan De Witte informed the board of his intention to retire.

De Witte plans to retire following the appointment of a successor. Integra anticipates that appointment to come by the end of 2024. Additionally, the company appointed Stuart Essig, Integra chair, to the role of executive chair, effective immediately.As executive chair, Essig’s role entails driving shareholder value and ensuring an effective transition.

Essig became a non-executive chair in 2012 and previously served as Integra’s CEO from 1997 to 2012.

“We are grateful to Jan for his leadership and commitment to Integra and the role he has played in advancing our portfolio and building upon our legacy of innovation,” Essig said in a news release. “Jan’s personal decision to retire from Integra…

Osso VR picks new CEO as former leader transitions to new role

Osso VR announced today that it appointed Greg Born as its new CEO as Justin Barad transitions out of the role into a new position.

Born’s focus in the corner office centers around driving growth and expansion in the procedural training space. Osso VR develops academic programs with virtual reality (VR) training modules and simulations. Its platform, which features Osso Enterprise and Osso Academy, gives healthcare professionals ways to share, practice and learn new skills using hyper-realistic VR training.

The company offers modules in specialties including orthopedics, urology, cardiology, pediatrics and trauma. It also works with a number of leading medical device manufacturers worldwide. Earlier this month, it even launched a controller-free feature for its platforms.

Justin Barad founded the company and served as CEO for the past seven years. He intends to move into a chief strategy officer role to spearhead innovation efforts.

“A…

A high-ranking BD executive is set to retire

Dave Hickey. [Image from BD]BD (NYSE: BDX) + announced today that its EVP and President of Life Sciences, Dave Hickey, intends to retire this year.

Hickey plans for his retirement to go into effect on July 1, 2024. He originally joined BD in 2014, serving as president of Diagnostic Systems. He took over as president of Integrated Diagnostic Solutions in 2019 and began leading the Life Sciences segment in January 2021.

Prior to joining BD, Hickey held a range of executive leadership positions at Siemens Healthcare.

Read: Dave Hickey explains BD’s diagnostics business strategy.

“For over a decade at BD, Dave has demonstrated a strong, strategic and innovative approach, empowering his teams to deliver impactful results through a growth mindset and developing incredible talent and next-gen leaders at BD,” said Tom Polen, chair, CEO and president. “We wish him a…

Mitral valve repair company NeoChord has a new CEO

New NeoChord CEO Todd Berg. [Image from Metavention]NeoChord announced that it appointed Todd Berg as its new CEO to oversee its programs for mitral valve repair.

Minneapolis-based NeoChord develops technology for the delivery of artificial chords to treat mitral valve regurgitation. In the role, Berg oversees the clinical and commercial programs for the transeptal and transapical repair of damaged mitral valve chords.

The company’s DS1000 transapical (TA) chord repair system holds commercial marketing authorization in Europe. Its use spans the placement of more than 5,000 successful neochordae in more than 2,000 patients. The company’s NeXus transseptal (TS) chord repair system incorporates the same proprietary, suture-based anchor elements as DS1000. It’s currently in feasibility clinical trials.

Taking over the oversight of these products, Berg brings with him significant medtech experience over more than 30 years. He most recently serv…

The Bakken Medical Devices Center gets a new director

Hubert Lim, PhD, the incoming director of the Bakken Medical Devices Center at the University of Minnesota. [Image courtesy of BMDC]The Bakken Medical Devices Center at the University of Minnesota announced today that a longtime biomedical engineering professor will become its new director.

Hubert Lim, PhD, has been at the University of Minnesota for 14 years. He’s presently a professor in the Biomedical Engineering and Otolaryngology Departments at the university’s College of Science and Engineering.

In addition, Lim is active in the medtech startup community. He’s the chief scientific officer of Neuromod Devices (Dublin and Lisle, Illinois), which is developing a tinnitus treatment device) and chief scientific officer of SecondWave Systems (Minneapolis), which is developing a wearable ultrasound device for treating immune disorders.

Initially established in 2007 and located in the Mayo Building on the University of Minnesota Twin Cities …